Clinical Trials Browser

ascrinvacumab × Other solid neoplasm × Clear all

NCT01486368 2023-08-04

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT00557856 2015-10-19

A First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid Tumors

Phase 1 Completed

70 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumors